Metabolic risk in drug-resistant tuberculosis: prevalence of type 2 diabetes and its association with disease severity

Le résumé fourni par la source

Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis, remains a global health challenge, further complicated by the co-prevalence of Type 2 Diabetes Mellitus (T2DM), particularly in drug-resistant TB (DR-TB) cases. This dual burden worsens clinical severity, leads to poor treatment outcomes, and prolongs infectivity. This study assessed the prevalence of T2DM among DR-TB patients and evaluated clinical-radiological correlations, alongside the relationship between HbA1c and 7-point glucose profiles. Methods: A cross-sectional study of 104 microbiologically confirmed DR-TB patients. Diabetes was diagnosed using ADA criteria. Demographics, clinical features, radiology, HbA1c, and 7-point glucose profiles were analyzed. Results: T2DM prevalence was 41.3% in DR-TB patients, with significant associations found between T2DM, older age, and higher BMI. Radiological abnormalities included infiltrates (32.7% upper, 32.7% middle zones), consolidation (30.8%), and cavities (20.2%). No significant association was found between diabetes and radiographic extent (p> 0.05). HbA1c demonstrated a strong positive correlation with mean 7-point glucose values (r=0.579; p=0.03). Conclusions: T2DM is highly prevalent among DR-TB patients. Routine screening and integrated TB–diabetes care are essential. HbA1c remains reliable for diagnosis and monitoring even during active TB disease.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.